Latest Post

U = U: The evidence is in. Spreading the word that undetectable = untransmissable is the next crucial step

By Murray Penner of Prevention Access Campaign Undetectable = Untransmittable, or U=U, is a clear, effective, simple way to convey the fact that a person living with HIV who is on antiretroviral therapy and whose virus is suppressed cannot transmit HIV to sexual partners. In 2016, Prevention Access Campaign, a health equity initiative with the […]

More »

Recent Posts

CDC announces publication of TB treatment trial results showing four month regimen as effective as six month

The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed six-month regimen will inform guidelines that can significantly ease the burden of the disease on patients, their families, and health services worldwide, the U.S. Centers for Disease Control and […]

More »

Science Speaks wants to hear from you

Science Speaks, the global infectious disease blog produced by the Infectious Diseases Society of American and its HIV Medicine Association, is seeking input from its readers on how we can best keep you posted on breaking news and analysis of infectious diseases developments around the world. Your answers to a brief survey will help us […]

More »
More Recent Posts »

Live Blog Archive

CODEL Video

Click above for a video on our Congressional study tour to Africa, and click here to read more.

HIV

U = U: The evidence is in. Spreading the word that undetectable = untransmissable is the next crucial step

By Murray Penner of Prevention Access Campaign Undetectable = Untransmittable, or U=U, is a clear, effective, simple way to convey the fact that a person living […]

Tuberculosis

CDC announces publication of TB treatment trial results showing four month regimen as effective as six month

The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]

Research & Development

Can unprecedented success in COVID vaccine development boost prospects for an HIV vaccine?

By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]

Policy

As environmental destruction accelerates the spread of emerging infections, we need to talk

By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]